Talphera(TLPH) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update New sites accelerate registrational study enrollment - 15 patients have been enrolled in the NEPHRO study which remains on track with completion projected by the end of the year Cash and cash equivalents at June 30, 2025 were $6.8 million Conference call and webcast to be held Thursday, August 14, 2025 at 4:30 pm ET SAN MATEO, Calif., August 14, 2025 – Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty ...